Literature DB >> 31588532

Diseases Predisposing to Adrenocortical Malignancy (Li-Fraumeni Syndrome, Beckwith-Wiedemann Syndrome, and Carney Complex).

Anne Jouinot1,2, Jérôme Bertherat3,4.   

Abstract

Adrenocortical malignancies can occur in the context of several tumor predisposition syndromes.The Carney complex (CNC) is responsible for the majority of primary pigmented nodular adrenal diseases and is more rarely associated with adrenocortical carcinoma (ACC). Other core manifestations of CNC include cardiac and cutaneous myxomas, lentiginosis, somatotroph pituitary adenomas, Sertoli tumors, melanocytic schwannoma, and thyroid, breast, and bone tumors. CNC is mostly due to germline inactivating mutations of PRKAR1A.The majority of childhood ACC are related to genetic predisposition. The Beckwith-Wiedemann syndrome (BWS) is an overgrowth and tumor predisposition syndrome due to genetic or epigenetic alterations at the 11p15 locus. Classical tumor spectrum of BWS includes embryonal tumors and childhood ACC. The Li-Fraumeni syndrome (LFS) is a devastating tumor predisposition syndrome, due to germline inactivating mutations of TP53, and characterized by a high, various, and early-onset cancer risk. LFS spectrum includes premenopausal breast cancer, soft-tissue sarcoma, osteosarcoma, central nervous system tumor, and ACC, accounting for 50-80% of pediatric cases. Finally, germline predisposition affects up to 10% of adult ACC patients, mostly in part of LFS and Lynch syndrome.This chapter focuses on the diagnosis, screening, and management of adrenal tumors in part of these tumor predisposition syndromes.

Entities:  

Keywords:  Beckwith–Wiedemann syndrome; Carney complex; Li–Fraumeni syndrome; adrenocortical carcinoma; primary micronodular adrenal hyperplasia

Mesh:

Year:  2019        PMID: 31588532     DOI: 10.1007/978-3-030-25905-1_9

Source DB:  PubMed          Journal:  Exp Suppl        ISSN: 1664-431X


  4 in total

Review 1.  Melanoma in patients with Li-Fraumeni syndrome (Review).

Authors:  Florica Sandru; Mihai Cristian Dumitrascu; Aida Petca; Mara Carsote; Razvan-Cosmin Petca; Adina Ghemigian
Journal:  Exp Ther Med       Date:  2021-11-24       Impact factor: 2.447

Review 2.  Disorders of the adrenal cortex: Genetic and molecular aspects.

Authors:  Georgia Pitsava; Andrea G Maria; Fabio R Faucz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-29       Impact factor: 6.055

Review 3.  Adjuvant Therapy in Adrenocortical Carcinoma: Reflections and Future Directions.

Authors:  Sara Bedrose; Marilyne Daher; Lina Altameemi; Mouhammed Amir Habra
Journal:  Cancers (Basel)       Date:  2020-02-22       Impact factor: 6.639

4.  Clinical, Genetic, and Prognostic Features of Adrenocortical Tumors in Children: A 10-Year Single-Center Experience.

Authors:  Evelina Miele; Angela Di Giannatale; Alessandro Crocoli; Raffaele Cozza; Annalisa Serra; Aurora Castellano; Antonella Cacchione; Maria Giuseppina Cefalo; Rita Alaggio; Maria Debora De Pasquale
Journal:  Front Oncol       Date:  2020-10-15       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.